Fundz

Forcyte Biotechnologies, Inc. reported raising $1 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEJan 10, 2019$1M of $2M raised

Amount Raised

$1 Million

$1 Million sold, per SEC Form D (first sale Jan 10, 2019)

Round Type

Seed

Los AngelesInformation Technology

Quick answer

Forcyte Biotechnologies, Inc. raised $1 Million in a Seed round, dated January 10, 2019. Forcyte Biotechnologies, Inc. is based in Los Angeles, California, United States.

How much did Forcyte Biotechnologies, Inc. raise?
Forcyte Biotechnologies, Inc. raised $1 Million in a Seed round on January 10, 2019.
What does Forcyte Biotechnologies, Inc. do?
Forcyte has efficiently scaled to routinely screen 10,000 wells per screening day and has, to-date, collected contractility data on >2.4 million cell-drug-timepoint combinations from >360 million individual primary..
Where is Forcyte Biotechnologies, Inc. based and how big is it?
Forcyte Biotechnologies, Inc. is based in Los Angeles, California, United States.

Source: Fundz verified event record.

Who to call at Forcyte Biotechnologies, Inc., and when

A new round usually means Forcyte Biotechnologies, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Forcyte Biotechnologies, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Forcyte Biotechnologies, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Forcyte Biotechnologies, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Forcyte Biotechnologies, Inc.

Location

11957 DARLINGTON AVENUE

Los Angeles, California, United States

About

Forcyte has efficiently scaled to routinely screen 10,000 wells per screening day and has, to-date, collected contractility data on >2.4 million cell-drug-timepoint combinations from >360 million individual primary human cells, including smooth muscle cell types, fibroblasts, and other tissue cells.The company, internally and via partnerships, is launching a pipeline of programs targeting mechanically-active disease processes including fibrotic diseases, dystrophies, and hyper- and hypo-responsiveness in organs including the bladder, airway, blood vessels, and uterus.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Forcyte Biotechnologies, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Forcyte Biotechnologies, Inc.'s next move

See what Strategic adds

Forcyte Biotechnologies, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.